Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations.
Marando L, Csizmar CM, Patnaik MM.
Haematologica. 2025 Jan 1;110(1):22-36. doi: 10.3324/haematol.2024.286061.
Chronic myelomonocytic leukemia - a review.
Thomopoulos TP, Bouhla A, Papageorgiou SG, Pappa V.
Expert Rev Hematol. 2021 Jan;14(1):59-77. doi: 10.1080/17474086.2021.1860004. Epub 2020 Dec 12.
How I diagnose and treat chronic myelomonocytic leukemia.
Patnaik MM.
Haematologica. 2022 Jul 1;107(7):1503-1517. doi: 10.3324/haematol.2021.279500.
Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment.
Elmariah H, DeZern AE.
Curr Hematol Malig Rep. 2019 Jun;14(3):154-163. doi: 10.1007/s11899-019-00509-9.
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
Coltro G, Patnaik MM.
Curr Oncol Rep. 2019 Nov 14;21(11):101. doi: 10.1007/s11912-019-0855-6.
Chronic myelomonocytic leukemia (CMML).
Geissler K.
Wien Med Wochenschr. 2023 Feb;173(1-2):1-2. doi: 10.1007/s10354-023-01003-x. Epub 2023 Jan 25.
Genetic complexity of chronic myelomonocytic leukemia.
Patel AB, Deininger MW.
Leuk Lymphoma. 2021 May;62(5):1031-1045. doi: 10.1080/10428194.2020.1856837. Epub 2020 Dec 18.
Chronic myelomonocytic leukemia.
Bennett JM.
Curr Treat Options Oncol. 2002 Jun;3(3):221-3. doi: 10.1007/s11864-002-0011-6.
Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu B.
Clin Transl Oncol. 2021 Sep;23(9):1731-1742. doi: 10.1007/s12094-021-02585-x. Epub 2021 Apr 16.
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.
Rezazadeh A, Deininger M, Atallah E.
Curr Treat Options Oncol. 2023 Aug;24(8):1036-1051. doi: 10.1007/s11864-023-01105-z. Epub 2023 Jun 10.
